• Alphabet旗下Isomorphic Labs的总裁科林·默多克（Colin Murdoch）向《财富》杂志透露，该实验室正准备启动人工智能设计药物的人体试验。这家源自DeepMind ...

新智元报道 编辑：YHluck ...

2025年，Google旗下的Isomorphic Labs宣布将启动首个人类临床试验，标志着AI药物设计技术的重大进展。该公司由DeepMind分拆而成，致力于通过AI技术攻克人类面临的各种疾病。Isomorphic Labs总裁Colin ...

Google旗下的Isomorphic Labs正准备启动AI设计药物的人体临床试验。这家从DeepMind分拆出来的公司，正在把「用AI治愈所有疾病」的野心变成现实。

Isomorphic Labs总裁Colin Murdoch在巴黎接受Fortune采访时透露：「 有人正坐在我们伦敦国王十字区的办公室里，与AI合作设计抗癌药物。 这正在发生。 」 ...

Alphabet’s Isomorphic Labs, spun out of DeepMind, is preparing to start human trials of AI-designed drugs after raising $600 ...

One day we hope to be able to say — well, here’s a disease, and then click a button and out pops the design for a drug to ...

Google DeepMind's Isomorphic Labs is set to begin human trials of drugs designed by artificial intelligence, marking a ...

癌症研发新药#】据《财富》杂志 6 日报道，Isomorphic Labs 总裁兼谷歌 DeepMind 首席商务官 Colin Murdoch 透露，谷歌旗下专注于药物研发的神秘机构 Isomorphic Labs 即将启动由 AI 设计的新药的人体试验。 Murdoch 在巴黎受访时表示：“我们在伦敦国王十字的办公室里，已经有人与 AI 协作，为癌症开发新药。” 经过多年筹备，Isomorph ...

Google DeepMind's drug discovery arm, Isomorphic Labs, is “ready" to begin human trials of its AI-designed drugs.In an interview with Fortune, Colin Murdoch, President of Isomorphic Labs and ...

Google DeepMind's drug discovery company, Isomorphic Labs, is gearing up to launch the human trials of its AI-designed drugs.

Alphabet’s Isomorphic Labs is preparing to launch human trials of AI-designed drugs, its president, Colin Murdoch, told Fortune. Born from DeepMind’s AlphaFold breakthrough, the company is pairing ...